Compared with lisinopril, the drugs collectively had a dementia hazard ratio of 0.86, indicating a lower rate of new diagnoses over follow-up.Compared with lisinopril, the drugs collectively had a dementia hazard ratio of 0.86, indicating a lower rate of new diagnoses over follow-up.
Preprint: cohort study of adults starting ARBs or lisinopril, against people starting lisinoprilVascular dementia
Limit: Dementia diagnoses drawn from health records and claims may miss undiagnosed cases
In a prospective cohort followed for a median 11.9 years, 5,648 dementia cases were linked to particle pollution from domestic, transport and industrial sources.In a prospective cohort followed for a median 11.9 years, 5,648 dementia cases were linked to particle pollution from domestic, transport and industrial sources.
GLP-1 receptor agonist initiation was associated with a lower hazard of incident dementia than DPP-4 inhibitors (HR 0.64) in diabetic COVID-19 survivors.GLP-1 receptor agonist initiation was associated with a lower hazard of incident dementia than DPP-4 inhibitors (HR 0.64) in diabetic COVID-19 survivors.
Incidence of all-cause dementia was 1.26 per 1000 person-years with RAS inhibitors versus 1.89 with calcium channel blockers (HR 0.68).Incidence of all-cause dementia was 1.26 per 1000 person-years with RAS inhibitors versus 1.89 with calcium channel blockers (HR 0.68).